MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-24-0006893
Avenza Pharmaceuticals Private Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹10.69 Cr
▲ 162% YoY
Net loss · FY 2025
₹13.92 Cr
Net margin -130.2%
EBITDA · FY 2025
-₹4.14 Cr
EBITDA margin -38.8%
Authorised capital
₹13 Cr
Registered with MCA
Paid-up capital
₹12.61 Cr
Issued & subscribed
Open charges
₹58.4 Cr
Satisfied ₹23.8 Lakh
Company age
11 yrs
Est. 2015
Employees · EPFO
78
Provident fund records
About Avenza Pharmaceuticals Private Limited
Data last updated:
Avenza Pharmaceuticals Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 October 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24132GJ2015PTC084912. Its GSTIN is 24AANCA8832C1ZR (Gujarat).
The company has an authorised share capital of ₹13 Cr and a paid-up capital of ₹12.61 Cr. It is led by directors including Dhruvalkumar Jayantilal Patel and Vedant Nandkishore Maheshwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 705 Atlantis Heights Sarabhai Compound Vadi Wadi, Vadodara, Gujarat, India – 390003.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.69 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹13.92 Cr (net margin -130.2%) and EBITDA of -₹4.14 Cr (EBITDA margin -38.8%).
The company has about 78 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹58.4 Cr and satisfied charges of ₹23.8 Lakh on record. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹9.59 Cr; the latest was in January 2021.
Avenza Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0006893). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website avenzapharma.com.
Company details
CIN U24132GJ2015PTC084912
Registration Number 084912
Incorporation Date 28 October 2015
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-24-0006893
Key People
Dhruvalkumar Jayantilal Patel Director Vedant Nandkishore Maheshwari Director Dilavar Alibhai Abhavani Director Recognitions & Rankings of Avenza Pharmaceuticals
Contact details
Avenza Pharmaceuticals Private Limited's registered office is in Vadodara, Gujarat. Its website is avenzapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address705 Atlantis Heights Sarabhai Compound Vadi Wadi, Vadodara, Gujarat, India – 390003
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Avenza Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Avenza Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Avenza Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Avenza Pharmaceuticals Private Limited, buy the company report.
Financials of Avenza Pharmaceuticals Private Limited
FY 2025 filings availableAvenza Pharmaceuticals Private Limited reported revenue of ₹10.69 Cr (up 162% YoY) for FY 2025.
Revenue · FY 2025
₹10.69 Cr ▲ 162%
Net loss · FY 2025
₹13.92 Cr margin -130.2%
EBITDA · FY 2025
-₹4.14 Cr margin -38.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 162%
EBITDA CAGR growth
1 year
▲ 57%
Revenue rose 162% in the latest year. EBITDA rose 57% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.14 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13.92 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -38.8% | ||||
| Net Profit Margin | -130.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avenza Pharmaceuticals Private Limited, buy the company report.
Board of directors of Avenza Pharmaceuticals Private Limited
Avenza Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhruvalkumar Jayantilal Patel Also directs: CCR Sports LLP, Centurion Healthcare Private Limited, Fabveda Wellness Private Limited and 1 more | Director | 28 Oct 2015 | 11 Years 0 Months | Current |
| Vedant Nandkishore Maheshwari Also directs: Mypher Pharmaceuticals LLP, Aviance Pharmaceuticals Private Limited, Avoure Pharma & Healthcare Private Limited and 2 more | Director | 28 Oct 2015 | 11 Years 0 Months | Current |
| Dilavar Alibhai Abhavani Also directs: Express Pharmaceuticals Private Limited | Director | 28 Oct 2015 | 11 Years 0 Months | Current |
Auditor
Avenza Pharmaceuticals Private Limited is audited by JAYAM & Associates LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAYAM & Associates LLP | FY 2024 | 130968W/W100605 |
Shareholding
The shareholding of Avenza Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Avenza Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹58.4 Cr
Satisfied charges
₹23.8 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Jan 2021 | 100412050 | Others | ₹29.2 Cr | Open | |
| 20 Dec 2020 | 100412446 | Others | ₹29.2 Cr | Open | |
| 20 May 2022 | 100590948 | Indian Bank | ₹23.8 Lakh | Satisfied |
To see the full charge records of Avenza Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Avenza Pharmaceuticals Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹9.59 Cr; the latest was in January 2021.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹9.59 Cr
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Jan 2021 | Funding round | ₹9.59 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Avenza Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avenza Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Avenza Pharmaceuticals Private Limited has a workforce of 78 employees on its EPFO records as of Feb 27, 2025, across 1 active EPFO establishment.
Employee count
78
Active EPFO establishments
1
Employee growth
2.63%
GST
Avenza Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AANCA8832C1ZR | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Avenza Pharmaceuticals Private Limited, buy the company report.
Recent activity
Avenza Pharmaceuticals Private Limited has 3 board changes on record since 2015: 3 appointments. The latest: Dhruvalkumar Jayantilal Patel was appointed as Director on 28 Oct 2015.
AGM
Avenza Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 20 May 2022 via Charge ID 100590948 with Indian Bank was fully satisfied on 28 Aug 2025.
Filing
Avenza Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others of Rs. 29.20 Cr registered on 06 Jan 2021 with Charge ID 100412050 was modified on 06 Oct 2022.
Charges
A charge with Others of Rs. 29.20 Cr registered on 20 Dec 2020 with Charge ID 100412446 was modified on 06 Oct 2022.
Charges
A charge with Indian Bank amounted to Rs. 0.24 Cr with Charge ID 100590948 was registered on 20 May 2022.
Charges
A charge with Others amounted to Rs. 29.20 Cr with Charge ID 100412050 was registered on 06 Jan 2021.
Charges
A charge with Others amounted to Rs. 29.20 Cr with Charge ID 100412446 was registered on 20 Dec 2020.
Appointed
Dhruvalkumar Jayantilal Patel was appointed as Director.
Appointed
Dilavar Alibhai Abhavani was appointed as Director.
Appointed
Vedant Nandkishore Maheshwari was appointed as Director.
Incorporation
28 Oct 2015
Avenza Pharmaceuticals Private Limited was registered on 28 Oct 2015 with Roc Ahmedabad & aged 11 years 10 days as per MCA records.
Frequently asked questions
Avenza Pharmaceuticals is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 October 2015 (11+ years old) and is registered under CIN U24132GJ2015PTC084912.
Avenza Pharmaceuticals has 3 current directors:
- Dhruvalkumar Jayantilal Patel - Director
- Vedant Nandkishore Maheshwari - Director
- Dilavar Alibhai Abhavani - Director
The latest financial statements of Avenza Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Avenza Pharmaceuticals is 24AANCA8832C1ZR, registered in Gujarat.
The CIN (Corporate Identification Number) of Avenza Pharmaceuticals is U24132GJ2015PTC084912. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avenza Pharmaceuticals was incorporated on 28 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Avenza Pharmaceuticals has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹9.59 Cr; the latest was in January 2021.
Dhruvalkumar Jayantilal Patel was appointed as Director on 28 Oct 2015. Dilavar Alibhai Abhavani was appointed as Director on 28 Oct 2015. Vedant Nandkishore Maheshwari was appointed as Director on 28 Oct 2015.
Yes, Avenza Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-24-0006893).
Avenza Pharmaceuticals can be reached through the website avenzapharma.com. Its registered office is in Vadodara, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages